Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yan Yu
Observed names:
Y. Yan,
Yu Yan
Institution:
Fujian University of Traditional Chinese Medicine
Observed institutions:
Fujian University of Traditional Chinese Medicine,
Harbin Medical University,
Third Affiliated Hospital of Harbin Medical University,
General Hospital of Shenyang Military Region,
Bethune International Peace Hospital,
Haisco Pharmaceutical Group Co., Ltd. (China)
show all 6
ORCID:
0000-0001-9214-8157
Observed ORCID:
0000-0001-9214-8157
OpenAlex ID:
A5101724239
Design, Synthesis, and Evaluation of Novel 2,6-Disubstituted Phenol Derivatives as General Anesthetics
2017
·
Linlin Qin
, Lei Ren
, et al.
·
Journal of Medicinal Chemistry
·
228
The Predictive Model Construction for Immune-Related Adverse Events in Non-Small Cell Lung Cancer Patients Receiving Immunotherapy
2023
·
Weitong Gao
, Qianqian Liu
, et al.
·
Technology in Cancer Research & Treatment
·
19
Modulation of DAPK1 expression by its alternative splice variant DAPK1-215 in cancer
2025
·
QingShui Wang
, ShuYun Weng
, et al.
·
Journal of Translational Medicine
·
7
PDF
1204 A Phase I study evaluating the pharmacokinetics (PK) and pharmacodynamics (PD) of the oral pan-phosphoinositide-3 kinase (PI3K) inhibitor GDC-0941
2009
·
R. Kristeleit
, D. Sarker
, et al.
·
European Journal of Cancer Supplements
·
6
Anti-inflammatory activity and mechanism of action of Banxia Xiexin Decoction on DSS-induced ulcerative colitis in mice
2025
·
Xiuli Zhang
, Yan Yu
, et al.
·
Journal of Ethnopharmacology
·
5
223 POSTER Pharmacokinetics and pharmacodynamic biomarkers for the pan-PI3K inhibitor GDC-0941: Initial Phase I evaluation
2008
·
P. LoRusso
, D. Sarker
, et al.
·
European Journal of Cancer Supplements
·
5
Bioequivalence study of two perindopril tert-butylamine tablet formulations in healthy Chinese subjects under fasting and fed conditions: A randomized, open-label, single-dose, crossover trial
2021
·
Qiuying Li
, Zhen Hao
, et al.
·
Biomedicine & Pharmacotherapy
·
3
PDF
Pharmacokinetic Study of Olmesartan Medoxomil Tablets on Chinese Healthy Volunteers in Vivo after Single Dose Orally
2014
·
Yu Yan
·
Medical & Pharmaceutical Journal of Chinese People's Liberation Army
389 A phase I study evaluating the pharmacokinetics (PK) and pharmacodynamic (PD) activity of the dual PI3K/mTor inhibitor GDC-0980 administered QW
2010
·
A.J. Wagner
, G.C. Jayson
, et al.
·
European Journal of Cancer Supplements
Effects of continuous venovenous hemofiltration on ceftazidime pharmacokinetics in patients with multiple organ failure.
2010
·
Huang Xin-zhong
, Jie Gao
, et al.
·
Zhongguo shiyong neike zazhi
Show more works
View as search
Works count:
10
Citation count:
273
H-index:
5
I10-index:
2
Year
Topic
Type